ChromaCode
7 known investors
ChromaCode develops a High-Definition PCR (HDPCR) multiplexing platform that enables genomic solutions for oncology and precision medicine, offering faster results and cost-effective workflows through automated interpretation and cloud-based software.
Investors · 7
In the news
- ChromaCode Announces Strategic Investment to Advance Development and Application of HDPCR Platform Technology for Use in Oncology Genomicsprnewswire.com · 2023
- ChromaCode - 2026 Company Profile, Team, Funding & Competitors - Tracxntracxn.com · 2021
- Carlsbad’s ChromaCode raises $38 million to pursue low-cost testing platform for coronavirussandiegouniontribune.com · 2020
- ChromaCode Raises $10 Million Series C Financing From Adjuvant Capitalprnewswire.com · 2020
- ChromaCode Raises $28M in Series C Funding - FinSMEsfinsmes.com · 2019
- ChromaCode raises USD12m in Series B fundraising - Private Equity Wireprivateequitywire.co.uk · 2017